UK Quantum Biomedical Hub Secures £902,000 ($1.2 Million USD) Allocation to Develop Clinical Sensing and Imaging Hardware
Summarize this article with:
The UK National Quantum Biomedical Research Hub (Q-BIOMED) has been awarded £902,000 ($1.2 million USD) from the Engineering and Physical Sciences Research Council (EPSRC). Delivered through the government’s Accelerating Capability Fund—a flexible financial mechanism anchored to the UK’s £2.5 billion National Quantum Strategy—the capital injection supports six targeted work packages to develop and translate quantum sensing hardware into clinical medical environments. The initiative establishes new academic partnerships across five research institutions to integrate quantum devices directly into the diagnostics, neuroimaging, and surgical pipelines of the National Health Service (NHS). Technical Architecture & Quantum Hardware Enhancements The six funded work packages target core hardware and engineering barriers across distinct diagnostic and biomedical modalities: OPM-Driven Neuroimaging for Ultra-High-Field MRI: Ultra-high-field human brain imaging using 7 Tesla (7T) and forthcoming National 11.7T MRI systems faces image distortion due to rapidly varying magnetic field gradients. To resolve this, Q-BIOMED is partnering with the University of Cambridge to implement Optically Pumped Magnetometer (OPM) quantum field probes. This setup provides continuous, real-time actual gradient readouts during active scans to stabilize image reconstruction. The system utilizes an open-source framework combining Pulseq sequences and BART image reconstruction pipelines. Spin-Enhanced Multiplexed Diagnostics: While nitrogen-vacancy (NV) centers in nanodiamonds achieve a 103 to 105-fold improvement in lateral flow detection limits over standard gold nanoparticles, engineering multi-biomarker multiplexed assays is restricted by the single microwave resonance of NV centers. Partnering with the University of Glasgow, this project replaces nanodiamonds with chemically tunable molecular nanoparticles. These molecular spin systems support distinct, intrinsic microwave resonances, enabling simultaneous multi-biomarker detection via Optically Detected Magnetic Resonance (ODMR).
Magnetically Actuated Reporter Proteins: Investigating how tissue morphology and cellular structures evolve in living organoids over time requires non-invasive imaging. Because standard solid-state quantum sensors exhibit poor expression inside living biological structures, Q-BIOMED is collaborating with the University of Oxford to engineer magnetically actuated reporter proteins. These biological reporters function as in vivo quantum sensors, enabling real-time, non-invasive monitoring of reactive oxygen species, temperature fluctuations, and mechanical strain via three-dimensional radio and magnetic-field control. OPM Sleep Neurophysiology Platform: In partnership with the University of Sussex, researchers will integrate a minimal-hardware configuration consisting of one to three custom OPMs to track discrete sleep stages (such as non-rapid eye movement versus rapid eye movement). Operating alongside classical contrastive learning EEG classifiers, the optimized, high-bandwidth quantum sensors aim to isolate high-frequency neurophysiological biomarkers to assist in the early identification of neurodegenerative conditions like Alzheimer’s and Parkinson’s diseases. Time-Resolved Singlet Oxygen Luminescence Detection (TSOLD): Collaborating with the University of Glasgow and Heriot-Watt University, the hub is integrating advanced photon-counting hardware to execute TSOLD, providing a direct methodology to measure singlet oxygen lifetimes across various organic photosensitizers and biological media. The resulting data library will support the construction of high-precision singlet oxygen dosimetry instrumentation for laser-based clinical oncology, chemical synthesis, and water purification. Clinical Mapping & Deployment Frameworks To ensure these hardware innovations successfully bridge the gap between academic laboratories and medical deployment, the final work package establishes a formal clinical integration pipeline in partnership with UCLPartners. This group is executing a comprehensive clinical needs mapping exercise across active NHS care pathways to explicitly isolate medical diagnostics and patient monitoring tasks where high-sensitivity quantum measurements deliver a clear statistical advantage over existing classical diagnostic tools. By anchoring technical engineering loops directly to verified user-led hospital requirements, the framework seeks to mitigate downstream procurement friction, providing a verified pathway for the long-term adoption of quantum-enhanced biomedical devices within the national healthcare infrastructure. You can review the official institutional award announcement via the Q-BIOMED hub news repository here. For an expanded technical breakdown of the underlying superconducting and atomic sensing components deployed across the national hub network, access the primary National Quantum Computing Centre program index here. May 29, 2026